See more : KRISHNA FILAMENT INDUSTRIES LI (KRIFILIND.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Neuland Laboratories Limited (NEULANDLAB.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neuland Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- UiPath Inc. (PATH) Income Statement Analysis – Financial Results
- Titan Minerals Limited (TTTNF) Income Statement Analysis – Financial Results
- Protalix BioTherapeutics, Inc. (PLX.TA) Income Statement Analysis – Financial Results
- TTW Public Company Limited (TTWPF) Income Statement Analysis – Financial Results
- AJR Infra and Tolling Limited (GAMMNINFRA.NS) Income Statement Analysis – Financial Results
Neuland Laboratories Limited (NEULANDLAB.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neulandlabs.com
About Neuland Laboratories Limited
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.59B | 11.91B | 9.25B | 9.24B | 7.58B | 6.46B | 5.13B | 5.73B | 5.10B | 4.65B | 4.66B | 4.61B | 4.49B | 3.94B | 2.78B | 3.07B |
| Cost of Revenue | 7.34B | 6.14B | 5.54B | 5.59B | 4.78B | 4.43B | 3.20B | 3.26B | 3.16B | 3.00B | 2.95B | 3.17B | 3.23B | 3.13B | 2.18B | 2.46B |
| Gross Profit | 8.25B | 5.77B | 3.72B | 3.66B | 2.80B | 2.03B | 1.93B | 2.47B | 1.94B | 1.65B | 1.71B | 1.43B | 1.25B | 806.99M | 606.76M | 607.07M |
| Gross Profit Ratio | 52.92% | 48.47% | 40.18% | 39.55% | 36.95% | 31.40% | 37.62% | 43.09% | 38.04% | 35.52% | 36.66% | 31.08% | 27.94% | 20.50% | 21.79% | 19.79% |
| Research & Development | 349.92M | 277.58M | 277.23M | 210.66M | 174.11M | 166.32M | 140.51M | 119.52M | 109.52M | 82.42M | 108.26M | 90.26M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 309.17M | 262.92M | 156.93M | 134.89M | 147.98M | 126.72M | 178.75M | 104.63M | 95.04M | 563.08M | 34.26M | 24.29M | 0.00 | 362.37M | 367.03M | 348.95M |
| Selling & Marketing | 339.36M | 295.79M | 274.02M | 204.83M | 119.91M | 118.09M | 81.51M | 57.33M | 115.73M | 81.45M | 265.70M | 135.12M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.58B | 558.72M | 430.95M | 339.73M | 267.90M | 244.81M | 260.26M | 104.63M | 95.04M | 644.54M | 814.56M | 702.35M | 0.00 | 362.37M | 367.03M | 348.95M |
| Other Expenses | 0.00 | 97.48M | 10.82M | 13.35M | 13.33M | 9.96M | 37.46M | 1.65B | 1.20B | 23.48M | 23.16M | 7.72M | 922.67M | 120.72M | 101.44M | 36.04M |
| Operating Expenses | 2.93B | 3.58B | 2.76B | 2.56B | 2.08B | 1.65B | 1.64B | 1.76B | 1.29B | 1.16B | 1.16B | 989.43M | 922.67M | 483.09M | 468.47M | 384.99M |
| Cost & Expenses | 10.27B | 9.72B | 8.30B | 8.15B | 6.85B | 6.08B | 4.84B | 5.02B | 4.45B | 4.16B | 4.11B | 4.16B | 4.15B | 3.61B | 2.65B | 2.85B |
| Interest Income | 82.27M | 15.56M | 9.95M | 16.68M | 21.62M | 24.96M | 7.89M | 9.11M | 7.50M | 7.84M | 8.36M | 10.38M | 9.75M | 9.27M | 8.32M | 7.03M |
| Interest Expense | 139.97M | 130.67M | 95.34M | 118.20M | 161.53M | 99.12M | 130.60M | 145.32M | 157.46M | 183.27M | 236.48M | 313.30M | 275.78M | 240.92M | 208.87M | 105.32M |
| Depreciation & Amortization | 597.00M | 527.77M | 490.40M | 396.83M | 312.80M | 258.63M | 221.04M | 192.28M | 157.43M | 153.20M | 149.39M | 146.22M | 148.91M | 154.11M | 135.59M | 73.70M |
| EBITDA | 4.75B | 2.82B | 1.45B | 1.63B | 1.06B | 618.63M | 549.66M | 1.08B | 822.24M | 676.49M | 767.25M | 659.68M | 479.39M | 478.01M | 261.92M | 295.78M |
| EBITDA Ratio | 30.46% | 23.64% | 15.41% | 17.00% | 13.19% | 8.71% | 9.61% | 14.44% | 14.40% | 12.56% | 15.03% | 12.55% | 10.69% | 12.14% | 9.41% | 9.64% |
| Operating Income | 5.32B | 2.31B | 960.90M | 1.10B | 735.99M | 384.48M | 290.06M | 709.15M | 649.86M | 489.52M | 550.49M | 441.89M | 330.48M | 323.90M | 138.29M | 222.08M |
| Operating Income Ratio | 34.12% | 19.36% | 10.38% | 11.86% | 9.71% | 5.95% | 5.66% | 12.38% | 12.74% | 10.53% | 11.82% | 9.59% | 7.37% | 8.23% | 4.97% | 7.24% |
| Total Other Income/Expenses | -1.30B | -8.79M | 21.10M | -1.05B | -206.76M | -181.10M | -749.88M | -98.08M | -207.02M | -276.07M | -238.24M | -253.50M | -234.71M | -274.73M | -236.43M | -75.95M |
| Income Before Tax | 4.01B | 2.16B | 821.63M | 1.05B | 529.23M | 203.37M | 139.34M | 494.18M | 420.03M | 247.22M | 345.54M | 189.24M | 8.31M | 49.38M | -98.14M | 146.13M |
| Income Before Tax Ratio | 25.76% | 18.11% | 8.88% | 11.40% | 6.98% | 3.15% | 2.72% | 8.63% | 8.24% | 5.32% | 7.42% | 4.11% | 0.19% | 1.25% | -3.52% | 4.76% |
| Income Tax Expense | 1.01B | 522.29M | 183.41M | 247.03M | 367.12M | 38.96M | 18.72M | 166.15M | 149.24M | 87.90M | 78.00M | 28.08M | -17.39M | -3.30M | -28.93M | 26.93M |
| Net Income | 3.00B | 1.64B | 638.22M | 806.31M | 162.11M | 164.42M | 120.63M | 328.03M | 273.25M | 159.47M | 268.07M | 138.63M | 25.61M | 52.89M | -69.05M | 119.23M |
| Net Income Ratio | 19.25% | 13.73% | 6.90% | 8.72% | 2.14% | 2.55% | 2.35% | 5.73% | 5.36% | 3.43% | 5.76% | 3.01% | 0.57% | 1.34% | -2.48% | 3.89% |
| EPS | 233.89 | 127.45 | 49.74 | 62.85 | 12.64 | 13.06 | 10.81 | 42.01 | 30.76 | 18.67 | 33.84 | 17.33 | 4.05 | 8.06 | -10.57 | 18.24 |
| EPS Diluted | 233.89 | 127.45 | 49.74 | 62.85 | 12.64 | 13.06 | 10.81 | 42.01 | 30.75 | 18.66 | 33.83 | 17.31 | 4.04 | 8.05 | -10.57 | 18.21 |
| Weighted Avg Shares Out | 12.83M | 12.83M | 12.83M | 12.83M | 12.83M | 12.59M | 11.15M | 11.15M | 8.88M | 8.54M | 7.92M | 8.00M | 6.33M | 6.53M | 6.53M | 6.53M |
| Weighted Avg Shares Out (Dil) | 12.83M | 12.83M | 12.83M | 12.83M | 12.83M | 12.59M | 11.15M | 11.15M | 8.89M | 8.54M | 7.93M | 8.01M | 6.33M | 6.54M | 6.53M | 6.53M |
Source: https://incomestatements.info
Category: Stock Reports